Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 33 Neoplasms 17 Prostatic Neoplasms 14 Lung Neoplasms 12 Carcinoma, Hepatocellular 11 Carcinoma, Non-Small-Cell Lung 10 Multiple Myeloma 9 Colorectal Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Papillomavirus Infections 6 Pain, Postoperative 6 Neoplasm Metastasis 6 Leukemia, Myeloid, Acute 6 Stomach Neoplasms 5 Recurrence 5 Liver Neoplasms 5 Lymphoma, Non-Hodgkin 4 Kidney Neoplasms 4 Heart Failure 4 Glioma 4 Febrile Neutropenia 4 Carcinoma, Renal Cell 4 Brain Neoplasms 4 Warts 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Rectal Neoplasms 3 Pituitary Neoplasms 3 Pancreatic Neoplasms 3

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Nitrofurantoin 1 Linezolid 1 Fluconazole 1 Ciprofloxacin 1 Cefuroxime 1 Amoxicillin-Potassium Clavulanate Combination 1 Amoxicillin 1 Amdinocillin Pivoxil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Cystectomy × Clear all

NCT06709196 2025-01-09

REINFORCE

Rigshospitalet, Denmark

Phase 4 Recruiting

Cystectomy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡